Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

Kidney International

Volumn 45, Issue 3, 1994, Pages 861-867

  Gansevoort, Ron T ^a   De Zeeuw, Dick ^a   De Jong, Paul E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE BLIND PROCEDURE;

EID: 0028295765     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1994.113     Document Type: Article

References (36)

1. DE ZEEUW D, HEEG JE, DE JONG PE: The antiproteinuric effect of angiotensin converting enzyme inhibitors in human renal disease, in International Yearbook of Nephrology, edited by ANDREUCCI VE, FINE LG, London, Springer Verlag, 1992, pp. 95-113
2. TOLINS JP, RAIJ L: Angiotensin converting enzyme inhibitors and progression of chronic renal failure. Kidney Int 38(Suppl 30):S118-S122, 1990
3. EISENBACH GM, VAN LIEW JB, BOYLAN JW: Effect of angiotensin on the filtration of protein in the rat kidney: A micropuncture study. Kidney Int 8:80-87, 1975
4. BOHRER MP, DEEN WM, ROBERTSON CR, BRENNER BM: Mechanism of angiotensin II induced proteinuria in the rat. Am J Physiol 233:F13-F21, 1977
5. OLIVETTI G, KITHIER K, GIACOMELLI F, WIENER J: Characterization of glomerular permeability and proteinuria in acute hypertension in the rat. Kidney Int 25:599-607, 1984
6. YOSHIOKA T, RENNKE HG, SALANT DJ, DEEN WM, ICHIKAWA I: Role for abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res 61:531-538, 1987
7. DORER FE, KAHN JR, LENTZ KE, LEVINE M, SKEGGS LT: Hydrolysis of bradykinin by angiotensin-converting enzyme. Circ Res 34:824-827, 1974
8. HUTCHISON FN, MARTIN VI: Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome. Am J Physiol 258:F1237-F1244, 1990
9. FENOY FJ, SCICLI G, CARRETERO O, ROMAN RJ: Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension 17:1038-1044, 1991
10. HAJJ-ALI AF, ZIMMERMAN BG: Kinin contribution to renal vasodilator effect of captopril in rabbit. Hypertension 17:504-509, 1991
11. MATTSON DL, ROMAN RJ: Role of kinins and angiotensin II in the renal hemodynamic response to captopril. Am J Physiol 260(29): F670-F679, 1991
12. HUTCHISON FN, WEBSTER SK: Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis. Am J Physiol 263:F311-F318, 1992
13. VENIANT M, CLOZEL JP, HESS P, FISCHLI W: Effects of renin-angiotensin system blockade in guinea pigs. Hypertension 19:255-262, 1992
14. BOHEN E, YEUN J, YUAN C, CHEN S, MOORE J, PAMNANI MB: Chronic effects of Dup 753 and enalapril in 25% reduced renal mass rats with streptozocin induced diabetes and hypertension. (abstract) J Am Soc Nephrol 3:755, 1992
15. KON V, FOGO A, ICHIKAWA I: Bradykinin causes selective efferent arteriolar dilatation during angiotensin I converting enzyme inhibition. Kidney Int 44:545-550, 1993
16. HEEG JE, DE JONG PE, VAN DER HEM GK, DE ZEEUW D: Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition. Kidney Int 40:734-741, 1991
17. WEXLER RR, CARINI DJ, DUNCIA JV, JOHNSON AL, WELLS GJ, CHIU AT, WONG PC, TIMMERMANS PBMWM: Rationale for the chemical development of Angiotensin II receptor antagonists. Am J Hypertens 5:209S-220S, 1992
18. TIMMERMANS PBMWM, BENFIELD P, CHIU AT, HERBLIN WF, WONG PC, SMITH RD: Angiotensin II receptors and functional correlates. Am J Hypertens 5:221S-235S, 1992
19. RHALEB NE, ROUISSI N, NANTEL F, D'ORLEANS-JUSTE P, REGOLI D: Dup 753 is a specific antagonist for the angiotensin receptor. Hypertension 17:480-484, 1991
20. WATANABE N, KAMEI S, OHKUBO A, YAMANAKE M, OHSAWA S, MARINO K, TOKUDA K: Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem 32/8:1551-1554, 1986
21. DONKER AJM, VAN DER HEM GK, SLUITER WJ, BEEKHUIS H: A radioisotope method for simultaneously determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20:97-103, 1977
22. KWARTS E, BEUKENVELD G, GAZEDAM J: Evaluation of a simple colorimetric assay for serum angiotensin-converting enzyme: Comparison with a new ion-pair liquid chromatography-assisted assay. Ann Clin Biochem 19:227-232, 1982
23. COHEN EL, GRIM CE, CONN JW, BLOUGH WM JR, GUYER RB, KEM DC, LUCAS CP: Accurate and rapid measurement of plasma renin activity by radioimmunoassay. Results in normal and hypertensive people. J Lab Clin Med 77:1025-1038, 1971
24. SUZUKI H, FERRARIO CM, SPETH RC, BROSHNIKAN KB, SMEBY RR, DE SILVA P: Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs. Hypertension 5(Suppl 1): 139-148, 1983
25. CAMPBELL MJ, GARDNER MJ: Calculating confidence intervals for some non-parametric analyses, in Statistics with Confidence, edited by GARDNER MJ, ALTMAN DG, London, British Medical Journal, 1989
26. ALTMAN DG: Non-parametric two way analysis of variance, in Practical Statistics for Medical Research, London, Chapman and Hall, 1991, pp. 334-335
27. DUNCAN DB: Multiple range and multiple F-tests. Biometrics 11:1-42, 1955
28. NELSON E, ARCURI K, IKEDA L, SNAVELY D, SWEET C: Efficacy and safety of losartan in patients with essential hypertension. (abstract) Am J Hypertens 5:20A, 1992
29. WEIDMANN P, BOEHLEN LM, DE COURTEN: Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 8:582-584, 1993
30. KASISKE BL, KALIL RSN, MA JZ, LIAO M, KEANE WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
31. MUNAFO A, CHRISTEN Y, NUSSBERGER J, SHUM LY, BORLAND RM, LEE RJ, WAEBER B, BIOLLAZ J, BRUNNER HR: Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clin Pharmacol Ther 51:513-521, 1992
32. LAFAYETTE RA, MAYER G, PARK SK, MEYER TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
33. IMAMURA A, MACKENZIE HS, HUTCHISON FN, PLOTH DW: Albuminuria and the effects of chronic renin angiotensin system inhibition in 2-kidney, 1 clip hypertensive rats. (abstract) J Am Soc Nephrol 3:521, 1992
34. DIVISH B, POLLOCK DM, POLAKOWSKI J, OPGENORTH TJ: Effect of AII receptor blockade in rats with reduced renal mass. (abstract) J Am Soc Nephrol 3:737, 1992
35. SALADINI D, JOVER B, RIBSTEIN J, MIMRAN A: Renal compensation to uninephrectomy and the renin-angiotensin system. (abstract) J Am Soc Nephrol 3:478, 1992
36. GANSEVOORT RT, DE ZEEUW D, DE JONG PE: Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney Int 44:579-584, 1993